Kirsten Peters

University of Western Australia

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Wendy Davis

University of Western Australia

AUSTRALIA

View details

Scott Bringans

Head of Research

Proteome Sciences plc

AUSTRALIA

View details

Peter Galettis

Newcastle University

AUSTRALIA

View details

David Bruce

University of Western Australia

AUSTRALIA

View details

Timothy Davis

Professor

University of Western Australia

AUSTRALIA

View details

David Watson

Matthew Flinders Distinguished Professor of Surgery

Flinders University

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kirsten Peters

Research Interests

Explore related searches

Contact this professor

Articles (14)

Analytical and Clinical Performance of a Novel Immunoassay-Based Test System to Predict Diabetic Kidney Disease

A Clinical Validation of a Diagnostic Test for Esophageal Adenocarcinoma Based on a Novel Serum Glycoprotein Biomarker Panel: PromarkerEso

PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes

Identification of plasma protein biomarkers for endometriosis and the development of statistical models for disease diagnosis

Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores

The relationship between thyroid dysfunction, cardiovascular morbidity and mortality in type 2 diabetes

Evaluation of the clinical utility of the PromarkerD in-vitro test in predicting diabetic kidney disease and rapid renal decline through a conjoint analysis

Assessment of biomarkers associated with rapid renal decline in the detection of retinopathy and its progression in type 2 diabetes: The Fremantle Diabetes Study Phase II

The New and the Old: Platform Cross-Validation of Immunoaffinity MASS Spectrometry versus ELISA for PromarkerD, a Predictive Test for Diabetic Kidney Disease

Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes Study

PromarkerD Predicts Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS)

A robust multiplex immunoaffinity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney disease

Prevalence and incidence of thyroid dysfunction in type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of adults: The Fremantle Diabetes Study Phase II

Protein Network Analysis Identifies Changes in the Level of Proteins Involved in Platelet Degranulation, Proteolysis and Cholesterol Metabolism Pathways in AECOPD Patients

Collaborators (6)

Wendy Davis

Scott Bringans

Peter Galettis

David Bruce

Timothy Davis

David Watson

Make your next move.